Childhood Cancer STAR Reauthorization Act

United States117th CongressS-4120Senate
Updated: Jan 5, 2023

Summary

Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.

Bill texts

Available versions
View official text

3 versions available

Timeline

Latest companion bill action

HR-7630: Childhood Cancer STAR Reauthorization Act of 2022

Referred to the Subcommittee on Health.

  1. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  2. Presented to President.

    House of Representatives

  3. Became Public Law No: 117-350.

  4. Signed by President.